| 臺大學術典藏 |
2018-09-10T08:30:08Z |
HCV core gene polymorphisms correlate with liver fibrosis but not sustained virological response in patients with genotype 1 infection.
|
Chun-Jen Liu;Pei-Jer Chen;Chen-Hua Liu;Ding-Shinn Chen;Jia-Horng Kao; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:30:08Z |
HCV core gene polymorphisms correlate with liver fibrosis but not sustained virological response in patients with genotype 1 infection.
|
Chun-Jen Liu;Pei-Jer Chen;Chen-Hua Liu;Ding-Shinn Chen;Jia-Horng Kao; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:30:07Z |
Interleukin-28B genetic variations and response to interferon-based therapy: Asian perspectives.
|
Chen-Hua Liu;Jia-Horng Kao; CHEN-HUA LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:30:07Z |
Interleukin-28B genetic variations and response to interferon-based therapy: Asian perspectives.
|
Chen-Hua Liu;Jia-Horng Kao; CHEN-HUA LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:30:07Z |
Serum p53 gene polymorphisms and severity of hepatitis B or C-related chronic liver diseases in Taiwan.
|
Chun-Jen Liu;Pei-Jer Chen;Chen-Hua Liu;Ding-Shinn Chen;Jia-Horng Kao; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:30:07Z |
Serum p53 gene polymorphisms and severity of hepatitis B or C-related chronic liver diseases in Taiwan.
|
Chun-Jen Liu;Pei-Jer Chen;Chen-Hua Liu;Ding-Shinn Chen;Jia-Horng Kao; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:28:55Z |
Risk factors of hepatitis during Anti-tuberculous treatment and implications of hepatitis virus load
|
Wang, J.-Y.;Liu, C.-H.;Hu, F.-C.;Chang, H.-C.;Liu, J.-L.;Chen, J.-M.;Yu, C.-J.;Lee, L.-N.;Kao, J.-H.;Yang, P.-C.; LI-NA LEE; Chong-Jen Yu; JANN-YUAN WANG; CHEN-HUA LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:50Z |
Rifaximin treatment in hepatic encephalopathy [1]
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:50Z |
Role of Viral Factors in Modifying Weight-Related Effects on Disease Progression of Chronic Hepatitis C Patients
|
Hsu, C.;Kao, J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:50Z |
Treatment of chronic hepatitis B in Asia-Pacific countries: Is the Asia-Pacific consensus statement being followed?
|
Sung, J.J.Y.;Amarapurkar, D.;Chan, H.L.Y.;Cheng, J.;Kao, J.-H.;Han, K.-H.;Piratvisuth, T.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:50Z |
Use of statins and gallstone risk [1]
|
Hsu, C.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:50Z |
慢性丙型肝炎治疗的新进展：从病毒到宿主
|
許景盛;高嘉宏; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:49Z |
Intrathecal delivery of a mutant μ-opioid receptor activated by naloxone as a possible antinociceptive paradigm
|
Kao, J.H.;Chen, S.L.;Ma, H.I.;Law, P.Y.;Tao, P.L.;Loh, H.H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:49Z |
Letter to the editor
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:49Z |
Metformin improves sustained virologic response in difficult-to-cure hepatitis c: More questions than answers
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:49Z |
Optimal management of hepatocellular carcinoma: Challenges and opportunities
|
Lin, C.-L.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:49Z |
Outcomes of HCV treatment: Who does well and who does not?
|
Hsu, C.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:49Z |
Preoperative drainage in pancreatic cancer
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:48Z |
Clinical implications of hepatitis B virus variants
|
Lin, C.-L.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:48Z |
Cost-effectiveness analysis of roadmap models in chronic hepatitis B using tenofovir as the rescue therapy
|
Lui, Y.Y.-N.;Tsoi, K.K.-F.;Wong, V.W.-S.;Kao, J.-H.;Hou, J.-L.;Teo, E.-K.;Mohamed, R.;Piratvisuth, T.;Han, K.-H.;Mihm, U.;Wong, G.L.-H.;Chan, H.L.-Y.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:48Z |
From liver markers to life expectancy
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:48Z |
Hepatitis B e antigen seroconversion: A critical event in chronic hepatitis B virus Infection
|
Liaw, Yun-Fan; Lau, George K. K.; Kao, Jia-Horng; Gane, Edward; JIA-HORNG KAO; Liaw, Yun-Fan; Lau, George K. K.; Kao, Jia-Horng; Gane, Edward |
| 臺大學術典藏 |
2018-09-10T08:16:48Z |
Hepatitis C infection and metabolic syndrome.
|
JIA-HORNG KAO; Hsu, C.S.;Kao, J.H. |
| 臺大學術典藏 |
2018-09-10T08:16:48Z |
Hepatitis C virus infection, lipids, and coronary heart disease: A Pandora's box
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:47Z |
Vitamin D receptor gene polymorphisms and distinct clinical phenotypes of hepatitis B carriers in Taiwan
|
Huang, Y.-W.;Liao, Y.-T.;Chen, W.;Chen, C.-L.;Hu, J.-T.;Liu, C.-J.;Lai, M.-Y.;Chen, P.-J.;Chen, D.-S.;Yang, S.-S.;Kao, J.-H.; CHUN-JEN LIU; YI-WEN HUANG; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:47Z |
A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection
|
Tong, Myron John; Hsu, Leeyen; Hsien, Carlos; Kao, Jia-Horng; Durazo, Francisco Antonio; Saab, Sammy; Blatt, Lawrence Mitchell; JIA-HORNG KAO; Tong, Myron John; Hsu, Leeyen; Hsien, Carlos; Kao, Jia-Horng; Durazo, Francisco Antonio; Saab, Sammy; Blatt, Lawrence Mitchell |
| 臺大學術典藏 |
2018-09-10T08:16:47Z |
A novel antibody associated with autoimmune pancreatitis [4]
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:47Z |
Alanine aminotransferase, metabolic syndrome, and cardiovascular disease: A missing link
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:47Z |
Carvedilol versus variceal band ligation for prevention of the first variceal bleed
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:46Z |
Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B
|
Huang, Y.-W.;Chayama, K.;Tsuge, M.;Takahashi, S.;Hatakeyama, T.;Abe, H.;Hu, J.-T.;Liu, C.-J.;Lai, M.-Y.;Chen, D.-S.;Yang, S.-S.;Kao, J.-H.; CHUN-JEN LIU; YI-WEN HUANG; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:46Z |
Implications of hepatitis B virus genomic variations on treatment outcomes
|
Tseng, T.-C.;Liu, C.-J.;Kao, J.-H.; CHUN-JEN LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:46Z |
Metabolic syndrome on top of chronic hepatitis B: The more, the worse?
|
Chang, L.-C.;Chung, C.-S.;Liu, C.-J.;Kao, J.-H.; CHUN-JEN LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:40Z |
Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma. Epidemiologic and molecular biological aspects
|
Kao, J.-H.;Chen, P.-J.; Chen, D.-S.; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:39Z |
Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection
|
Hsu, C.-S.; Wang, C.-C.;Wang, P.-C.; Lin, H.H.; Tseng, T.-C.; Chen, C.-H.; Su, W.-C.; Liu, C.-J.; Chen, C.-L.; Lai, M.-Y.; Chen, P.-J.; Chen, D.-S.; Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:13:47Z |
Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection
|
Hsu, C.-S. and Liu, C.-H. and Liu, C.-J. and Hsu, S.-J. and Chen, C.-L. and Hwang, J.-J. and Lai, M.-Y. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H.; JUEY-JEN HWANG; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:13:44Z |
Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B
|
Su, T.-H. and Hsu, C.-S. and Chen, C.-L. and Liu, C.-H. and Huang, Y.-W. and Tseng, T.-C. and Liu, C.-J. and Chen, P.-J. and Lai, M.-Y. and Chen, D.-S. and Kao, J.-H.; YI-WEN HUANG; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; TUNG-HUNG SU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:13:43Z |
The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis C
|
Liu, C.-H.;Liang, C.-C.;Liu, C.-J.;Hsu, S.-J.;Lin, J.-W.;Chen, S.-I.;Hung, P.-H.;Tsai, H.-B.;Lai, M.-Y.;Chen, P.-J.;Chen, J.-H.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; HUNG-BIN TSAI; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:10:19Z |
Asymptomatic chronic hepatitis B virus infection does not increase the risk of diabetes mellitus: A ten-year observation
|
Huang, Z.-S.;Huang, T.-S.;Wu, T.-H.;Chen, M.-F.;Hsu, C.-S.;Kao, J.-H.; ZEI-SHUNG HUANG; TIEN-SHANG HUANG; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:04:53Z |
Recent advances in clinical application of gut hormones
|
Tseng, P.-H. and Wu, M.-S. and Kao, J.-H.; PING-HUEI TSENG; MING-SHIANG WU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:04:10Z |
HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses
|
Yu, M.-L. and Lee, C.-M. and Chuang, W.-L. and Lu, S.-N. and Dai, C.-Y. and Huang, J.-F. and Lin, Z.-Y. and Hu, T.-I. and Chen, C.-H. and Hung, C.-. and Wang, J.-H. and Chen, C.-L. and Kao, J.-H. and Lai, M.-Y. and Liu, C.-H. and Su, T.-H. and Wu, S.-S. and Liao, L.-Y. and Kuo, H.-T. and Chao, Y.-C. and Tung, S.-Y. and Yang, S.-S. and Chen, P.-J. and Liu, C.-J. and Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; TUNG-HUNG SU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:04:05Z |
Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C.
|
Chun-Jen Liu;Pei-Jer Chen;Hung-Bin Tsai;Chen-Hua Liu;Ding-Shinn Chen;Jia-Horng Kao; CHUN-JEN LIU; PEI-JER CHEN; HUNG-BIN TSAI; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:04:05Z |
Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C.
|
Chun-Jen Liu;Pei-Jer Chen;Hung-Bin Tsai;Chen-Hua Liu;Ding-Shinn Chen;Jia-Horng Kao; CHUN-JEN LIU; PEI-JER CHEN; HUNG-BIN TSAI; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:51Z |
GB virus-C/hepatitis G virus infection in Taiwan: A virus that fails to cause a disease?
|
Kao, J.-H.;Chen, D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:51Z |
Molecular methods of measurement of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection: Implications for occupational health practice
|
Kao, J.-H.;Heptonstall, J.;Chen, D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:51Z |
Prevalence and implication of TT virus infection: Minimal role in patients with non-A-E hepatitis in Taiwan
|
Kao, J.-H.;Chen, W.;Hsiang, S.-C.;Chen, P.-J.;Lai, M.-Y.;Chen, D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:50Z |
IL-10 promoter gene polymorphisms and sustained response to combination therapy in Taiwanese chronic hepatitis C patients
|
Chuang, J.Y.; Yang, S.S.; Lu, Y.T.; Hsieh, Y.Y.; Chen, C.Y.; Chang, S.C.; Chang, C.S.; Yeh, H.Z.; Kao, J.H.; JIA-HORNG KAO; Chuang, J.Y.; Yang, S.S.; Lu, Y.T.; Hsieh, Y.Y.; Chen, C.Y.; Chang, S.C.; Chang, C.S.; Yeh, H.Z.; Kao, J.H. |
| 臺大學術典藏 |
2018-09-10T07:39:50Z |
Peginterferon alfa-2b or alfa-2a with ribavirin for hepatitis C
|
Hsu, C.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:50Z |
Prevention of hepatocellular carcinoma in hepatitis B virus infection
|
Lim, S.G.;Mohammed, R.;Yuen, M.-F.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:49Z |
Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease
|
Wang, Chia-Chi;Lin, Shinn-Kuang;Tseng, Yuan-Fu;Hsu, Ching-Sheng;Tseng, Tai-Chung;Lin, Hans Hsien-Hong;Wang, Li-Yu;Kao, Jia-Horng; JIA-HORNG KAO; WANG, CHIA-CHI; LIN, SHINN-KUANG; TSENG, YUAN-FU; HSU, CHING-SHENG; TSENG, TAI-CHUNG; LIN, HANS HSIEN-HONG; WANG, LI-YU; KAO, JIA-HORNG |
| 臺大學術典藏 |
2018-09-10T07:39:49Z |
Esomeprazole for asthma [7]
|
Hsu, Ching-Sheng;Kao, Jia-Horng; JIA-HORNG KAO; HSU, CHING-SHENG; KAO, JIA-HORNG |
